The Patent Finder

Arigen Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Arigen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 10 of 10 · Back to Arigen Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,440,913Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient
Formerly held
Lapsed on the fee record
Ended Sep 13, 2020 · USPTO record
Lapsed on the fee recordEnded Sep 13, 2020USPTO record
US 7,968,588Injectable formulation of antibiotic and solution for intravenous administration thereof
Formerly held
Lapsed on the fee record
Ended Jun 28, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 28, 2019USPTO record
US 8,778,975Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
Formerly held
Lapsed on the fee record
Ended Jul 15, 2018 · USPTO record
Lapsed on the fee recordEnded Jul 15, 2018USPTO record
US 7,622,598Phenol derivatives and antitrypanosoma preventive/therapeutic agent comprising the same as active ingredient
Lapsed on the fee record
Ended Nov 24, 2017 · USPTO record
Lapsed on the fee recordEnded Nov 24, 2017USPTO record
US 7,618,950Method for treatment and prevention of herpes zoster by topical application
Formerly held
Lapsed on the fee record
Ended Nov 17, 2017 · USPTO record
Lapsed on the fee recordEnded Nov 17, 2017USPTO record
US 7,495,011Anti-coronavirus drug
Lapsed on the fee record
Ended Feb 24, 2017 · USPTO record
Lapsed on the fee recordEnded Feb 24, 2017USPTO record
US 6,773,710Recombinant canine distemper virus vaccine against canine distemper and leishmaniasis
Lapsed on the fee record
Ended Aug 10, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 10, 2016USPTO record
US 8,076,302Pyrimidine nucleoside derivatives and salts thereof
Formerly held
Lapsed on the fee record
Ended Dec 13, 2015 · USPTO record
Lapsed on the fee recordEnded Dec 13, 2015USPTO record
US 7,868,206Trihalomethionine derivative and pharmaceutical product containing the same
Lapsed on the fee record
Ended Jan 11, 2015 · USPTO record
Lapsed on the fee recordEnded Jan 11, 2015USPTO record
US 5,648,455Antibiotic WAP-8294A, method for preparing the same and antibacterial composition
Formerly held
Term ended
Term ended no later than Jul 15, 2017 · Low confidence
Term endedTerm ended no later than Jul 15, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited